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Abstract: Carbon nanotubes (CNTs) have been extensively investigated and employed for 
industrial use because of their peculiar physical properties, which make them ideal for many 
industrial applications. However, rapid growth of CNT employment raises concerns about 
the potential risks and toxicities for public health, environment, and workers associated with 
the manufacture and use of these new materials. Here we investigate the main routes of entry 
following environmental exposure to multi-wall CNTs (MWCNTs; currently the most widely 
used in industry). We developed a novel murine model that could represent a surrogate of a 
workplace exposure to MWCNTs. We traced the localization of MWCNTs and their possible 
role in inducing an innate immune response, inflammation, macrophage recruitment, and 
inflammatory conditions. Following environmental exposure of CD1 mice, we observed that 
MWCNTs rapidly enter and disseminate in the organism, initially accumulating in lungs and 
brain and later reaching the liver and kidney via the bloodstream. Since recent experimental 
studies show that CNTs are associated with the aggregation process of proteins associated with 
neurodegenerative diseases, we investigated whether MWCNTs are able to induce amyloid fibril 
production and accumulation. Amyloid deposits in spatial association with macrophages and 
MWCNT aggregates were found in the brain, liver, lungs, and kidneys of exposed animals. Our 
data suggest that accumulation of MWCNTs in different organs is associated with inflammation 
and amyloid accumulation. In the brain, where we observed rapid accumulation and amyloid 
fibril deposition, exposure to MWCNTs might enhance progression of neurodegenerative and 
other amyloid-related diseases. Our data highlight the conclusion that, in a novel rodent model 
of exposure, MWCNTs may induce macrophage recruitment, activation, and amyloid deposi-
tion, causing potential damage to several organs. 
Keywords: nanoparticles, animal model, environmental exposure, inflammation, amyloid 
fibrils, macrophages
Introduction
Nanostructures, a term that includes nanoparticles (NPs), nanotubes, and nanospheres, 
possess remarkable chemical and physical properties. For these reasons, they are cur-
rently manufactured and used in many industrial settings. Carbon nanotubes (CNTs) 
are one of the most versatile nanomaterials, due to their high tensile strength, ultralight 
weight, excellent conductibility, and thermal and chemical stabilities. Based on the 
number of graphene layers, CNTs are classified into single-wall CNTs and multi-wall 
CNTs (MWCNTs).1 MWCNTs are widely employed in industry, often as additives 
in plastics and coatings.
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However, reasonable concerns are being expressed about 
potential risks for workers and other individuals exposed 
to these novel, non-natural materials, in particular, through 
their manufacture, use, and disposal.2–4 In this context, a 
careful assessment and monitoring is needed for poten-
tial unexpected biological interactions and toxicities,5,6 in 
particular due to their biopersistence7–9 and potential for 
accumulation in organs. CNT toxicity has been reported in 
rodent models by different routes of administration, such as 
intratracheal instillation,8,10–13 inhalation,14 or intravenous,15,16 
subcutaneous17 and intraperitoneal injection.18,19 However, 
exposure to CNTs is likely to occur simultaneously by 
multiple routes of entry, as CNTs for their characteristics are 
able to diffuse in various environmental matrices.20 For these 
reasons, we investigated whether and how these NPs are able 
to enter into the organism and interact with biological systems 
following external exposure and trigger possible pathological 
processes resulting from long-term exposure to MWCNTs.
Investigation of toxicities induced by exposure to 
MWCNTs in vivo has been largely focused on pulmonary 
effects. The small diameter, the relatively long length, and 
biopersistence of CNTs have been likened to that of asbestos, 
and there are extensive concerns regarding the potential 
pulmonary health hazards of exposure to CNTs.14,20–23 The 
effects of pristine (nonfunctionalized) CNTs most commonly 
involve immune innate reactions, including enhancement of 
oxidative damage,24 fibrosis,13,22,23 collagen-rich granuloma 
formation,23 and inflammation.25–30 When entering biologi-
cal fluids, CNTs are rapidly coated by proteins, forming a 
biological protein corona.31,32 In particular, the hydrophobic 
interactions between CNTs and proteins could also play a role 
in inducing proteins to form a cross-sheet, a characteristic 
of amyloid.33,34 Amyloid fibrils can self-assemble into large 
insoluble structures, often associated with toxic properties.35 
Different matrix surfaces can influence amyloidogenesis.36 
In this context, data concerning the ability of CNTs to 
induce protein aggregation and amyloid fiber formation are 
controversial.37–40 The NLRP3 inflammasome, associated 
with immune responses to CNTs,27–30,41 activates release of 
IL-18,42 a cytokine associated with amyloid plaque formation 
in Alzheimer’s disease,43–46 a neurodegenerative disorder 
characterized by amyloid accumulation. For these reasons, 
we investigated the ability of CNTs to induce amyloid pro-
duction and deposition in vivo, an innate defense mechanism 
present in most eukaryotic phyla ranging from fungi and 
invertebrates47–49 to humans.50
We evaluated the effects of CNTs exposure in a murine 
model reflecting MWCNTs exposure in the environment. 
MWCNTs were added directly within the cage litter twice 
a week. The animals extensively agitate the litter as part 
of their normal activities, thus generating an aerosol and 
thereby exposing the respiratory and digestive tracts as 
well as skin. This model includes multiple routes of entry, 
essentially through aerosol inhalation and the digestive tract 
contact, both direct and indirect (through the physiological 
process of upper airway CNT trapping and respiratory tract 
mucus removal). The model can approximate to a workplace 
exposure to CNTs, where workers can be subjected to an 
uncontrolled direct and indirect exposure.
We observed that MWCNTs rapidly penetrated into 
the organism, accumulating as aggregates in the lungs, 
brain, liver, kidney, and intestine, respectively. We found 
MWCNTs in the peripheral blood and observed that aggre-
gates of MWCNT were associated with amyloid deposition 
and macrophage recruitment in most tissues.
Methods
cNT preparation
Commercially available and industrially employed Nanocyl 
thin MWCNTs NANOCYL™ NC7000 were obtained from 
Nanocyl (Sambreville, Belgium). The MWCNTs have an 
average 9.5 nm external diameter by 1.5 µm mean length 
with a surface area of 250–300 m2/g. They were manufac-
tured using a catalytic carbon vapor deposition process with 
a purity of 90%, 10% of metal oxide, and no amorphous car-
bon. In these experiments, the pristine MWCNTs were used 
directly without any chemical processing before use.
In vivo study design
The procedures involving animal handling and care conformed 
to institutional guidelines, in compliance with national and 
international laws and guidelines for the use of animals in 
biomedical research, and were approved by the local animal 
experimentation ethics committee and by the Italian Health 
Ministry. In this study, 40 male CD1 mice (6–8 weeks of age, 
Charles River, Calco, Italy) were used. The animals were 
housed with steel wire tops and corn-cob beddings, maintained 
in a controlled atmosphere with 12:12 dark–light cycle with free 
access to food and fresh water. The cages were accommodated 
in a cabinet equipped with high-efficiency particulate arrestance 
(HEPA) filters, which acted as a barrier preventing cross-
contamination between the exposed and control animals.
In our model, mice were exposed to 1.5 g MWCNTs/80 g 
litter by adding the dry MWCNTs into the wood shaving 
cage litter. The MWCNTs were gently mixed with litter, 
dispersing large aggregates, in order to obtain a homogeneous 
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dispersion of NPs. Animals (five per cage) were transferred 
into new cages containing MWCNT/litter twice a week. 
Controls consisted of animals that were housed similarly 
but without MWCNTs in the litter. The exposure dose was 
selected based on previous studies.51,52 Standard rodent diet, 
provided as pellets on the top of the cage, and water were 
provided ad libitum. The animals extensively agitate the 
litter as part of their normal behavior, thus generating an 
aerosol that contains MWCNTs and MWCNT-associated 
dusts, thereby exposing the skin and respiratory and digestive 
tracts similar to what might be found in an industrial setting 
using CNTs in an unrestricted and uncontrolled manner. 
Health status of the animals was monitored by examining 
skin alterations, reactivity to stimuli, body-weight, as well as 
food and liquid intake. The mice were sacrificed at 1 week, 
2 weeks, 3 weeks, 4 weeks, and 5 weeks after exposure to 
MWCNTs and organs (lungs, intestine, brain, kidneys, and 
liver) were excised for subsequent analysis.
Optical and transmission electron 
microscopy
The liver, lungs, kidneys, intestine, and brains were excised 
from the animals after the indicated exposure times. Tissue 
samples for hematoxylin and eosin (H&E), Thioflavin T, or 
immunofluorescence staining (see below) were embedded 
in polyfreeze tissue freezing medium (OCT; Polysciences, 
Inc., Warrington, PA, USA) and immediately frozen in liquid 
nitrogen. Cryosections (7 µm) were obtained with a Leica 
CM1850 cryotome. At least 10 samples for each tissue were 
scored for MWCNT aggregates by counting the aggregates 
found in five blinded fields for each H&E stained slide 
using a light microscope. Samples for transmission electron 
microscopy (TEM) were fixed in 4% glutaraldehyde, washed 
in 0.1 M cacodylate buffer pH 7.4, and postfixed with 1% 
osmic acid in cacodylate buffer, pH 7.4. After standard 
dehydration in ethanol series, samples were embedded 
in an Epon–Araldite 812 mixture and sectioned with a 
Reichert Ultracut S ultratome (Leica Microsystems, Wetzlar, 
Germany). Semithin sections were stained by conventional 
methods (crystal violet and basic fuchsin) and observed with 
a light microscope (Nikon Instruments, Melville, NY, USA). 
Thin sections were stained by uranyl acetate and lead citrate 
and observed with a JEOL 1010 electron microscope (JEOL, 
Tokyo, Japan).
Nanotubes detection and localization
To isolate MWCNTs from tissues, the samples from the 
organs and peripheral blood, obtained after 5 weeks of 
CNT environmental exposure, were digested in 5 N KOH 
(Sigma-Aldrich Co., St Louis, MO, USA) for 2 hours to 
remove all materials of biological origin. The CNTs, being 
resistant to 5 N KOH, remained after this digestion. The 
digested material was washed in distilled water to eliminate 
potassium salts, resuspended in 100 µL of distilled water, 
and dried onto a cover glass for scanning electron analysis. 
To enhance CNT signals, the cover glasses were sputter 
coated with a thin layer of gold and observed in backscat-
tered electron mode with a scanning electron microscope 
coupled with an energy dispersive X-ray analyzer (EDAX 
Genesis 2000).
Amyloid fibril characterization
Amyloid structures were identified according to LeVine,53 
by staining with Thioflavin T and detecting the amyloid-
specific yellow fluorescence. Cryosections, from selected 
samples where nanotubes were identified, were rehydrated 
and stained with 1% Thioflavin T in 0.1 M cloridric acid for 
3 minutes at room temperature at dark. Sections were washed 
with phosphate-buffered saline (PBS), incubated with 1% 
acetic acid, and after standard dehydration in ethanol series 
were mounted and observed with an Olympus BH2 micro-
scope through a filter set (excitation wavelength of 465 nm 
emission). Images were acquired with a DS-5M-L1 Nikon 
digital camera system. Amyloid structures were confirmed 
by Congo red staining and birefringence: cryosections were 
stained for 5 minutes with Congo red solution and hema-
toxylin, mounted, and observed under a polarized light using 
an Axioskop 2 microscope (Carl Zeiss Meditec AG, Jena, 
Germany).
Immunofluorescence
Cryosections (7 µm) from selected samples in which nano-
tubes were identified were treated for 30 minutes with PBS 
containing 2% bovine serum albumin (BSA) before the 
primary antibody incubation (4°C over night). The presence 
of CD68 (a macrophage marker) was assessed using specific 
primary antibody (1:100 dilution; Santa Cruz Biotechnology 
Inc.). After washing, incubation with a suitable secondary 
antibody conjugated with Cy5 (1:50 dilution; Santa Cruz 
Biotechnology Inc.) was performed for 90 minutes in a dark 
humid chamber. The PBS buffer used for washing steps and 
antibody dilutions contained 2% BSA. In control samples, 
primary antibody was omitted and samples were treated with 
BSA-containing PBS. Coverslips were mounted with Citif-
luor mounting medium and then observed under a fluorescent 
microscope (Nikon Instruments).
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Double-label immunofluorescence
Double-label immunofluorescence was performed to 
assess which cells were able to produce amyloid fibrils. 
Cryosections were first stained with Thioflavin T as 
described above and then incubated with an antibody 
against CD68. Thioflavin T (in green) and CD68 (in red) 
signals were observed under a fluorescent microscope 
(Nikon Instruments).
statistical analysis
MWCNT aggregates were counted in serial sections stained 
with H&E of lung, intestine, liver, kidney, and brain of 10 
MWCNTs-exposed CD1 mice. Each count is the mean value 
of five different fields per section observed from multiple 
animals.
Data were analyzed using GraphPad Prism software 
(GraphPad Software, Inc., La Jolla, CA, USA) and 
expressed as mean ± standard error of mean. Statistical 
analysis was performed using one-way ANOVA. Differ-
ences were considered statistically significant when P-values 
were ,0.05.
Results
exposure of cD1 mice to MWcNTs
Both MWCNT-exposed mice and control mice showed no 
overt pathological clinical signs. Exposed mice showed a 
good general health status, with normal reactivity to stimuli 
and no alterations in body-weight and food and liquid con-
sumption (data not shown). The examination of the directly 
involved organs (lung and intestinal tract) in MWCNT 
exposure showed no macroscopic morphological altera-
tions, as compared to controls, except for a darker color in 
the intestines (data not shown) and darker color of the feces. 
No macroscopic differences were observed in other organs 
of exposed mice (data not shown).
Detection of MWcNTs in tissues of 
exposed mice
Histological examination of sections from lungs, intestinal 
tract, livers, kidneys, and brains explanted from MWCNT-
exposed mice showed patches of dark material, absent in 
tissue sections from control animals in all tissues examined 
(Figure 1), that were likely MWCNT aggregates. The dark 
Figure 1 Histological analysis and quantification of MWCNT aggregates in exposed mice.
Notes: histological analysis of selected tissues from mice exposed to environmentally administered MWcNTs is shown. Dark deposits (arrowheads) corresponding to 
MWcNT aggregates were detectable. No dark deposits were observed in tissues from unexposed mice (ctrl); a full panel of representative tissues is shown. The scale bar 
for all photographs =100 µm.
Abbreviations: MWcNT, multi-wall carbon nanotube; ctrl, control; w, weeks.
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aggregates appearing after 1 week of exposure accumulated 
over time in all tissues; quantification indicated a statisti-
cally significant accumulation with substantial differences 
between tissues (Figure 2). The aggregates were initially 
found in the lungs since the first week (Figures 1 and 2) 
indicating that the respiratory tract is a major path of entry. 
The brains of exposed mice showed similar dark deposits 
since the second week (Figures 1 and 2) that appeared in 
Figure 2 Quantification of the histological analysis of MWCNT aggregates in exposed mice.
Notes: MWCNTs in five random microscopic fields were counted in the lung, liver, brain, kidney, and intestine and provided with relative statistical analysis (*P,0.05, 
**P,0.01, ***P,0.001, ****P,0.0001, as assessed by two-tailed t-tests).
Abbreviation: MWcNT, multi-wall carbon nanotube.
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a larger number but less aggregated than those observed 
in the lungs (Figure 1). Dark aggregates appeared in the 
liver of mice from the third week of MWCNT exposure 
(Figures 1 and 2). Aggregates were also detected in the 
kidneys of mice at late times of exposure (Figures 1 and 2). 
A similar pattern with accumulation initiating at 4 weeks 
and becoming statistically significant at 5 weeks, but with 
a reduced number of MWCNT aggregates, was found in 
the digestive tract of treated animals (Figures 1 and 2). 
These data suggest that the digestive tract is not a primary 
route of entry.
Morphological and chemical conformation 
of MWcNTs in tissues of exposed mice
The observation of dark deposits in lung, intestine, liver, 
and brain of MWCNT-exposed mice, not found in unex-
posed animals, appeared to be directly correlated with the 
presence of MWCNT aggregates in these organs (Figure 1). 
TEM and scanning electron microscopy (SEM) analyses, 
performed on tissues excised from exposed mice, confirmed 
our hypothesis that the dark deposits observed were effec-
tively MWCNTs. These analyses revealed accumulation of 
MWCNTs in the lung (Figure 3A–C), liver (Figure 3D–G), 
and brain (Figure 3H–K). In particular, in the brain of 
treated animals, MWCNTs were found dispersed both in 
the vasculature and in association with glial macrophages 
as demonstrated by TEM analysis (Figure 3H and I), sug-
gesting that macrophages constitute the cells primarily 
involved in the recognition of this exogenous (nonself) 
material.
The presence of MWCNTs in mouse tissues was addi-
tionally confirmed by taking advantage of the chemical 
resistance of CNTs. Selected samples from the tissue types 
where MWCNT aggregates were observed (lung, liver, and 
brain) from exposed and control groups were minced and 
digested with 5 N KOH. This treatment removes all materi-
als of biological origin, leaving behind resistant materials, 
including MWCNTs. The residual KOH-resistant material 
was collected by centrifugation, washed, and examined by 
SEM. This material clearly showed the characteristics of 
CNT aggregates (Figure 3C, G, and K). Similar structures, 
examined by SEM and TEM, were found in peripheral 
blood samples (Figure 3L and M) taken from MWCNT-
exposed mice. Morphologically, the aggregates derived 
from chemical digestion of tissue samples were very similar 
to that obtained from the stock MWCNTs with (Figure 3N) 
or without (Figure 3O) KOH treatment. No KOH-resistant 
materials were found in chemically digested tissues or blood 
from control mice.
SEM and EDAX analysis were performed on previously 
digested selected samples showing MWCNT aggregates 
(Figure 3P and Q). EDAX distribution clearly confirmed 
the presence of carbon (the principal CNT component) that 
overlaps with MWCNT aggregate present in SEM photos 
(Figure 3P and Q).
MWcNT aggregates correlate with 
inflammation
Since CNTs have been reported to be associated with 
inflammation3,9–11,14,22,25,28,41,54–56 that in turn is sustained by 
immune cell recruitment, we evaluated the presence of 
macrophages (the principal cell type involved) by examining 
the presence of CD68 positive cells (a common marker for 
macrophage identification) in association with MWCNT 
aggregates. The numbers of CD68 positive cells were 
increased in tissues (lung, brain, liver) in animals exposed to 
MWCNTs for 5 weeks, particularly in areas where MWCNTs 
aggregates were localized (Figure 5), suggesting induction 
of an inflammatory microenvironment.
During oxidative damage and inflammatory process, 
amyloidogenesis is often induced;48,49 thus, we investigated 
whether CNTs aggregation would be associated with the induc-
tion of amyloid deposition. The presence of amyloid fibrillar 
material, revealed by Thioflavin T and Congo red staining, 
was observed close to MWCNT aggregates. Localization of 
amyloid fibrils (Figure 4), forming a scaffold around the aggre-
gates of MWCNTs, was found in the 1) lungs (Figure 4A–D) 
of exposed mice around bronchioles and arteries and 2) 
liver (Figure 4E–J), near the bile ducts (Figure 4H and J). 
Amyloid deposition was particularly evident in the 3) brains 
(Figure 4K–P). We also found evidence of amyloid deposits 
in the 4) kidney (data not shown) of exposed animals.
The presence of amyloid fibrils was evidenced both by 
Congo red and Thioflavin T staining. Congo red staining 
(Figure 4A–D, G, H, M, and N), where the characteris-
tic birefringence under polarized light, was enhanced in 
MWCNT-exposed animals. Control animals that were not 
exposed to MWCNTs showed only faint or absent birefrin-
gence. Thioflavin T evidenced the presence of amyloidogenic 
material (in brilliant green) (Figure 4I–J, O, and P).
Double-immunofluorescence staining with Thioflavin 
T and anti-CD68 antibody (Figure 5) showed a clear 
co-localization between CD68 positive cells and areas of 
amyloid deposits in the lung (Figure 5, panel A), brain 
(Figure 5B), and liver tissues (Figure 5C) of MWCNT-
exposed animals, indicating that MWCNT aggregates induce 
macrophage recruitment, tissue inflammation, and amyloid 
deposition (Figure 5).
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Discussion
The broad industrial use of CNTs has led to concerns regard-
ing their potential health effects. Models of CNT in vivo 
pulmonary exposure routes still represent a debated topic. 
Although inhalation is clearly the most likely route, it is dif-
ficult to quantify exposure when using aerosol techniques.57 
Intranasal or intratracheal instillation are the most common 
administration techniques, but their use focuses on the lungs 
and may not take into account CNTs trapped in the upper 
respiratory tract and the subsequent digestive tract exposure. 
Further, CNTs tend to create large agglomerates when 
dispersed in aqueous suspension. Taken together, these could 
lead to an under- or overestimation of the toxicity induced 
by CNTs. To test the hypothesis that uncontrolled exposure 
Figure 3 Ultrastructural analysis of MWcNT aggregates in selected organs.
Notes: TeM and seM analyses of selected samples of murine tissues showed dark nanoparticle aggregates (arrowheads). exposed lungs (A–C), liver (D–G), and brain (H–K) 
in TeM analysis presented dark needle-like structures (arrowheads) with dimensions similar to MWcNTs (A, B, D–F). SEM analysis of the KOH-resistant material confirmed 
the presence of MWcNTs in the lungs (C), liver (G), brain (K), and blood (L, M) of 5-week MWcNT-exposed animals. These structures were morphologically similar to 
MWcNT from stock material that has been characterized by seM before (N) and after (O) KOh treatment, and were not found in unexposed animals. combination of seM 
analysis of MWcNT obtained by KOh corrosion of exposed liver (P) with eDaX (Q) clearly showed co-localization of carbon, indicating that the KOh-resistant material 
was MWcNT aggregates. scale bars: (A) 4.5 µm; (B) 1 µm; (C) 1 µm; (D) 1 µm; (E) 1 µm; (F) 0.5 µm; (G) 1 µm; (H) 7.5 µm; (I) 2.7 µm; (J) 2 µm; (K) 0.75 µm; (L) 0.5 µm; 
(M) 0.1 µm; (N) 1 µm; (O) 1 µm.
Abbreviations: TeM, transmission electron microscopy; seM, scanning electron microscopy; MWcNT, multi-wall carbon nanotubes; eDaX, energy dispersive X-ray 
analysis.
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to MWCNTs may adversely affect human health and safety, 
the route of MWCNTs in exposed animals represents a crucial 
point to mimic human exposure levels. We propose a novel 
environmental exposure model that we feel reflects a more 
realistic scenario of exposure compared to the usual instilla-
tion or inhalation procedures explored in several studies. The 
exposure dose of 18.75 mg/g litter of MWCNT was based on 
previous exposure studies.51,52 Further, our model was designed 
to reflect that of uncontrolled exposure of workers in industrial 
sectors where MWCNTs are employed, including individual 
variation due to, among other factors, subjective breathing rate, 
respiratory mucosal conditions, and direct and indirect contact 
with NPs and their related dusts. A recent study in a workplace 
that manufactures MWCNTs indicated exposures to elemental 
carbon of 5–10 µg/m3.58 In our model, MWCNT-exposed mice, 
agitating the litter, generates a NP aerosol that resembles the 
exposure route of workers who are in contact with NPs in the 
production process where they are employed, exposing the skin 
and respiratory and digestive tracts to MWCNTs. Our model 
reflects in a more realistic manner the subjective differences 
in MWCNTs exposure. In our model, the lungs were the first 
organs to show MWCNT accumulation and the digestive tract 
the last organ to show accumulation, suggesting that pulmo-
nary exposure represents the predominant route.
We also found MWCNTs in the blood and a rapid dis-
tribution to internal organs (brain, liver, kidney), indicating 
vascular transport. Further, we found a clear time-dependent 
MWCNT accumulation in all tissues. MWCNT aggregates 
were found after 1 week of exposure in the brains, indicat-
ing a rapid access of CNTs into this tissue. This could be 
because of either CNTs penetrating the lung and/or diges-
tive tract, entering into the peripheral circulation and then 
across the blood–brain barrier, or a direct transport from 
the olfactory nerve into the olfactory bulb59 and then to the 
rest of the brain. TEM analysis appeared to confirm this 
multimodal translocation of MWCNT to the brain as we 
found MWCNTs associated with brain vessels, dispersed 
throughout the tissue, and in association with microglia 
(Figure 2E).
CNTs have been previously associated with foreign body 
reactions,21,23 including migration, activation of immune 
cells and induction of frustrated phagocytosis,25 and acti-
vation of the NLRP3 inflammasome,3,27–30,41 leading to 
inflammation.60 The nanometer scale and needle shape of 
Figure 4 Detection of amyloid fibril deposits by Congo red and Thioflavin T staining.
Notes: In 5-week MWcNT-exposed mice, birefringence (arrowheads) following congo red staining indicating amyloid deposition was found in the lung (C, D), liver (G, H), 
and brain (M, N), while these were not found in the same tissues from unexposed mice (A, B, E, F, K, L). In exposed liver (I, J) Thioflavin T revealed that amyloid fibrils 
are in association with venules (v) and biliary ducts (d). In the brain (O, P), the amyloid fibrils surround the MWCNT aggregates in what appears to be a nonself response. 
The scale bar for all photographs =200 µm.
Abbreviation: MWcNT, multi-wall carbon nanotube.
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CNTs recall that of crocidolite asbestos fibers,54 and CNT 
administration has been associated with inflammation, 
fibrosis, and mesothelioma.19,54,61–66 Interestingly, previous 
studies documented the formation of granuloma and fibrosis 
upon pulmonary CNT exposure.12,14,21,24,25 We did not observe 
Figure 5 Association between amyloid fibril deposits and macrophage recruitment.
Notes: ThT and anti-CD68 antibody staining revealed co-localization between macrophages and amyloid fibril deposition. In the lung (A), brain (B), and the liver (C) from 
MWcNT-exposed mice, with respect to the controls (a–c), increased numbers of macrophages are evident in exposed animals (d–f), which are associated with areas of 
amyloid deposition. The scale bar for all photographs =100 µm.
Abbreviations: ThT, Thioflavin T; MWCNT, multi-wall carbon nanotube.
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these phenomena in our exposed mice. The results from 
our CNT-exposed mice are consistent with those reported 
from observations of workers exposed to MWCNTs, where 
no overall health aspects were observed even if there was 
modulation of some biomarkers.58
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Carboxylated MWCNT cytotoxicity can be reduced if 
this resistant material is enzymatically degraded.67,68 Degra-
dation of functionalized CNTs is associated with the degree 
of carboxylation, and can be obtained using peroxidases, in 
particular myeloperoxidase and eosinophil peroxidases,67,68 
continued for long periods (80 days). Unlike functionalized 
CNTs, unmodified pristine CNTs, which we used here, 
appear to be quite resistant to this type of degradation.67
Some of the toxic effects of CNTs have been associated 
with the presence of metal oxide content used during the 
manufacturing process.24 However, one study demonstrated 
that pulmonary toxicity was found to be independent of 
metal content.20 Here we examined industrial-grade pris-
tine MWCNTs since this product is widely used in many 
industrial processes. In addition, we associate this industrial 
material to the type of exposure that would be expected of 
industry workers, mimicking the entry and the possible 
effects expected. In our model, even with a short exposition 
schedule (up to 5 weeks), we observed aggregation and depo-
sition of MWCNTs in several organs without macroscopical 
and/or physiological alterations. Given the association with 
bile ducts in the liver and the relative hydrophobicity of 
MWCNTs, a partial clearance through the bile system and 
physiological elimination in the feces could be considered 
a possible route of removal. We observed that released and 
retained feces in MWCNT-exposed mice appeared as much 
darker material compared to unexposed mice (data not 
shown). However, this could also be due to oral uptake and 
digestive tract transit. We note that the intestinal tract was 
one of the organs where MWCNT aggregates were found 
much later than many other organs.
Macrophage recruitment and activation due to MWCNT 
aggregate in different organs is interestingly linked to the pro-
duction of amyloid fibril formation.48,49 This primitive defense 
mechanism employed by cells to aggregate melanin,37–40,48–50 
a strategy employed to build a scaffold for melanin assem-
bly, forming at least a barrier against pathogens or foreign 
bodies,48,49 has been recently associated with oxidative dam-
age and inflammation in several different types of cells.49
We demonstrate the presence of amyloid in lung, liver, 
and brain of MWCNT-exposed mice. In our mouse model, 
amyloid fibril formation in the lungs at the level of the bron-
chioles and arteries was observed, suggesting the presence 
and the passage of MWCNTs into the bloodstream, as also 
shown by treating whole blood with KOH. In vitro CNTs 
have been shown to transiently interact with endothelial 
cells and pass through the acidic lysosomal compartment,69 
consistently with the macrophage response to different types 
of CNTs.70 In the brain, amyloid was localized around aggre-
gates of MWCNT, indicating that amyloid deposition might 
be a barrier to contain nonself material. Further, in the livers 
of exposed animals, we observed amyloid fibrils associated 
with biliary ducts but absent in the parenchyma. A spatial 
association between macrophages, amyloid deposition, 
and MWCNT aggregates was found in exposed lung, liver, 
and brain,71 suggesting that MWCNTs could potentially be 
involved in promoting neurodegenerative and other amyloid-
associated diseases.
Conclusion
Our data reveal that CNTs can rapidly enter and disseminate 
in the organism after environmental exposure in a novel 
model system. The observed pharmacokinetic patterns 
suggest that, according to a first-pass effect mechanism, 
inhalation represents the main exposure route under our 
experimental conditions. The data indicate that the major 
organs affected are not only the lungs but also the brain 
and liver, where the accumulation results in inflammation 
and amyloid deposition. Clinically, secondary amyloidosis 
is associated with chronic inflammatory conditions and is 
characterized by a clinically silent phase followed by overt 
clinical signs depending on the organ(s) involved. A long-
term cytotoxicity due to CNT presence in the liver and in the 
central nervous system could promote several pathologies, 
such as cirrhosis or neurodegenerative diseases associated 
with amyloid deposits (in particular, in subjects with other 
risk factors). These data highlight new aspects of the potential 
risks for public health linked to environmental diffusion of 
CNTs and human exposure.
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